New to The Street Broadcasting Saturday June 13th 630pm est ACROSS BLOOMBERG TELEVISION IN THE U.S., LATIN AMERICA, AND MENA Jun 12, 2026 02:45PM
Medicus Pharma submits European filing for Teverelix prostate cancer study Jun 8, 2026 07:32AM
New to The Street Broadcasts Tonight on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM ET Jun 6, 2026 11:20AM
New to The Street Broadcasts Nationwide on Bloomberg Television Featuring "Opportunities To Consider(TM)" Across Artificial Intelligence, Healthcare Innovation, Fintech, Digital Assets, and Commoditie May 30, 2026 11:55AM
Medicus Pharma secures $22 million structured financing facility May 28, 2026 08:06AM
View Older Stories

May 23, 2026 12:25PM New to The Street Broadcasts Episode 753 Today at 6:30 PM EST Across Bloomberg Television U.S., MENA, and Latin America Featuring Leaders in VR Defense Training, AI Streaming, Healthcare Innovation, a
May 16, 2026 07:00AM New to The Street's Show #753 Airs Nationwide on Bloomberg Television Across the U.S., MENA and Latin America Featuring FreeCast (NASDAQ:CAST), Stardust Power (NASDAQ:SDST), Lost Soldier Oil and Gas,
May 14, 2026 05:28PM Medicus Pharma Ltd. (MDCX) Tops Q1 EPS by 30c
May 9, 2026 12:55PM New to The Street Broadcasts Show #752 on Bloomberg Television Featuring Graphene Manufacturing Group (OTCQX:GMGRF), T-REX Acquisition Corp (NASDAQ:TRXA), KITON, and Roadzen (NASDAQ:RDZN)
May 1, 2026 02:30PM GLOBAL MARKETS SPOTLIGHT: New to The Street Show #748 Delivers High-Impact CEO Interviews and Spotlight TV Commercials Across Bloomberg to 250M+ Households Worldwide
Apr 27, 2026 07:39AM Medicus Pharma CEO meets with House lawmakers on rare disease treatment
Apr 25, 2026 12:55PM New to The Street Broadcasts Show #746 Tonight on Bloomberg Television 6:30PM EST Featuring NRx Pharma (NASDAQ:NRXP), Performance Golf, Lost Soldier Oil & Gas, Dr. Lee Gause, and CISO Global
Apr 21, 2026 03:56AM Roth/MKM Starts Medicus Pharma Ltd. (MDCX) at Buy
Apr 18, 2026 10:00AM New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Gro
Apr 17, 2026 07:31AM Medicus Pharma seeks orphan drug status for SkinJect in Gorlin syndrome
Apr 11, 2026 12:30PM New to The Street to Broadcast on Fox Business on Monday, April 13, Featuring Virtuix Holdings (NASDAQ:VTIX), Medicus Pharma (NASDAQ:MDCX), YY Group Holdings (NASDAQ:YYGH), Vivos Therapeutics (NASDAQ:
Apr 7, 2026 08:30AM New to The Street Signs Medicus Pharma Ltd. (NASDAQ:MDCX) to Transformational 12-Part National Media Series Highlighting SkinJect(TM) and Teverelix(R) Platforms
Mar 30, 2026 08:55AM Medicus Pharma Ltd. (MDCX) PT Lowered to $9 at D. Boral Capital on dilution expectations
Mar 25, 2026 04:30PM Medicus Pharma Reports Full-Year 2025 Financial Results and Provides Corporate Update
Mar 18, 2026 07:30AM Medicus Pharma to discuss phase 2 results in investor fireside chat
Mar 18, 2026 07:30AM Medicus Pharma To Discuss Positive Skinject(R) Phase 2 Topline Results In Fireside Chat Hosted By Brookline Capital Markets Biotechnology Equity Research Analyst
Mar 14, 2026 12:00PM New to The Street Episode #737 Airs on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM EST
Mar 10, 2026 07:30AM Medicus Pharma Ltd. To Participate In The Longwood Miami CEO Forum
Mar 7, 2026 11:45AM New to The Street Broadcasts Tonight on Bloomberg Television at 6:30 PM EST - Shows 736, 737 and 738 Air Across the U.S., Latin America and MENA
Feb 28, 2026 11:30AM New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX)
Feb 12, 2026 07:30AM Medicus Pharma on Bloomberg World
Feb 10, 2026 08:30AM New to The Street Signs Six-Part Media Series Featuring Medicus Pharma Ltd.
Feb 10, 2026 07:31AM Medicus Pharma gets FDA clearance for Teverelix prostate cancer study
Jan 30, 2026 04:32PM Medicus Pharma (MDCX) files for 4.02M share offering by selling stockholders
Jan 23, 2026 07:30AM Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony
Jan 22, 2026 07:30AM Medicus Pharma amends LifeArc license, cuts Teverelix royalty to 2%
Jan 12, 2026 07:31AM Medicus Pharma study shows stable bone turnover with hormone suppression
Dec 30, 2025 09:29AM Medicus Pharma establishes $15.3 million at-the-market equity program
Dec 30, 2025 06:07AM Medicus Pharma (MDCX) files $100M mixed shelf
Dec 22, 2025 07:31AM Medicus Pharma signs non-binding AI analytics deal with Reliant AI
Dec 22, 2025 07:30AM Medicus Pharma Ltd. Announces Engagement With Reliant AI to Develop Artificial Intelligence (AI) Driven Clinical Data Analytics Platform
Dec 5, 2025 03:26PM Medicus Pharma enters $5.1 million warrant inducement agreement
Dec 5, 2025 03:20PM Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
Dec 1, 2025 08:00AM Medicus Pharma names Carolyn Bonner CFO alongside president role
Dec 1, 2025 08:00AM Medicus Pharma Ltd. Appoints Carolyn Bonner as Chief Financial Officer in Addition to Her Role as President
Nov 17, 2025 07:31AM Medicus Pharma files for FDA priority voucher for skin cancer treatment
Nov 17, 2025 07:30AM Medicus Pharma Ltd. Announces Filing of FDA Commissioner's National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
Nov 14, 2025 05:00PM Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights
Nov 13, 2025 07:31AM Medicus Pharma receives UK approvals to expand BCC skin cancer trial
Nov 13, 2025 07:30AM Medicus Pharma Ltd. Receives Full United Kingdom Regulatory and Ethical Approvals To Expand Phase 2 Clinical Study (SKNJCT-003) To Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
Nov 10, 2025 09:00AM BTV Spotlights: Netcoins, Kodiak, Sitka, Kneat, Highland Copper, Northstar Clean Technologies, Mineros, Stillwater, Medicus, & Newcore
Oct 29, 2025 07:30AM Medicus Pharma partners with Gorlin Syndrome Alliance for rare disease access
Oct 29, 2025 07:30AM Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for Skinject(TM) in Patients with Gorlin Syndrome
Oct 22, 2025 07:30AM Medicus Pharma begins UAE trial for skin cancer treatment
Oct 22, 2025 07:30AM Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
Oct 14, 2025 08:07AM The Vanderbilt Report: Medicus Pharma Ltd Built Three Separate Billion-Dollar Bets
Oct 13, 2025 07:30AM Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025
Oct 7, 2025 07:30AM Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE
Sep 29, 2025 05:06PM Medicus Pharma (MDCX) files for 7.5M share offering by selling stockholders
Sep 29, 2025 07:32AM Medicus Pharma gets FDA backing for basal cell carcinoma treatment path
View Older Stories